THE WELLCOME TRUST LIMITED

Their core work

The Wellcome Trust is one of the world's largest biomedical research charities, headquartered in London. Within H2020, their primary operational role has been sustaining and co-funding Europe PMC — the continent's leading open access life sciences literature repository. They also contribute health economics expertise to large-scale antimicrobial resistance diagnostics research. Their work sits at the intersection of research infrastructure funding and public health policy.

What they specialise in

How they've shifted over time

From 2014 to 2021, the Wellcome Trust's H2020 involvement was anchored almost entirely in open access infrastructure through successive Europe PMC co-funding rounds. Starting in 2019, they expanded into health research via VALUE-Dx, signaling an interest in applying their institutional weight to antimicrobial resistance — a global health priority. The shift suggests a move from pure infrastructure stewardship toward contributing health economics expertise in applied clinical research contexts.

Wellcome is expanding from research infrastructure funder into active participation in health-sector research consortia, particularly around antimicrobial resistance.

How they like to work

Wellcome strongly prefers the coordinator role, leading 3 of their 4 H2020 projects. Their Europe PMC grants are Coordination and Support Actions with relatively focused consortia, while their one participant role (VALUE-Dx) places them inside a larger research consortium. With 26 unique partners across 12 countries, they maintain a broad but not deeply repeated network — more of a hub connector than a loyal-partner type.

Wellcome has collaborated with 26 distinct partners across 12 countries, reflecting a wide European network. Their coordination of Europe PMC connects them to major national research funders and library systems across the continent.

What sets them apart

Wellcome occupies a rare position as a private charitable foundation operating as a research infrastructure provider within H2020 — most infrastructure coordinators are public bodies or universities. Their sustained, decade-long commitment to Europe PMC makes them the de facto steward of Europe's open access life sciences literature. For consortium builders, partnering with Wellcome signals institutional credibility and access to one of the best-connected funder networks in biomedical research.

Highlights from their portfolio

• ERC-EuropePMC-2020
  The largest single grant (EUR 1M) and third consecutive round of Europe PMC funding, demonstrating exceptional continuity and EU confidence in Wellcome's stewardship.
• VALUE-Dx
  Wellcome's only non-infrastructure project and sole participant role — marks their expansion into applied AMR diagnostics and health economics research.